URL copied to clipboard

Trending News

Akums Drugs and Pharmaceuticals  IPO GMP Today, Price Range, and Company Details

Akums Drugs and Pharmaceuticals IPO offers shares at ₹646 to ₹679, with a ₹180 Grey Market Premium. Available in 22 share lots, the subscription runs from July 30 to August 1, 2024.
Akums Drugs and Pharmaceuticals  IPO GMP Today, Price Range, and Company Details

As of July 29, 2024, Akums Drugs and Pharmaceuticals IPO has a ₹180 as Grey Market Premium, with a price range of ₹646 to ₹679 per share. Offering lots of 22 shares, the subscription window is open from July 30 to August 1, 2024.

Akums Drugs and Pharmaceuticals Limited IPO GMP Today

The Grey Market Premium (GMP) for Akums Drugs and Pharmaceuticals Limited is ₹180 as of July 29, 2024. This assessment coincides with a price of ₹646 to ₹679 per share for the IPO.

Akums Drugs and Pharmaceuticals Limited IPO Review

Akums Drugs and Pharmaceuticals Limited exhibits mixed financial results with decreased revenue but increased equity and liabilities, suggesting ongoing expansion efforts. Despite a dip in revenue, profitability shows improvement with a notable rise in PAT, hinting at better financial management and investor optimism.

The company’s debt-equity ratio has escalated, indicating a greater reliance on debt financing, yet total assets have grown, reinforcing business expansion potential. Despite a drop in EPS, a slight improvement in RoNW from negative figures suggests a recovering capability to generate shareholder returns.

To get a full IPO review, click here Akums Drugs and Pharmaceuticals IPO

Akums Drugs and Pharmaceuticals Limited IPO Date

Akums Drugs and Pharmaceuticals Limited will start accepting subscriptions from July 30, 2024, to August 1, 2024.

Akums Drugs and Pharmaceuticals Limited IPO Price

Akums Drugs and Pharmaceuticals Limited’s price range is ₹646 to ₹679 per share with a face value of ₹2 each.

Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited, founded in 2004, is India’s top CDMO, providing extensive services like R&D, regulatory support, testing, and manufacturing of formulations and APIs. As the largest CDMO by revenue, capacity, and client base, they hold a 30.2% market share in 2024, with a vast portfolio of 4,146 formulations across 60 dosage forms from ten manufacturing facilities.

How To Apply For Akums Drugs and Pharmaceuticals Ltd IPO?

To apply for the Akums Drugs and Pharmaceuticals IPO through Alice Blue, follow these steps:

1. Open a Demat and Trading Account with Alice Blue if you don’t have one.

2. Access IPO details for Akums Drugs and Pharmaceuticals on the Alice Blue platform.

3. Place your bid for the desired number of shares within the IPO’s price range.

4. Confirm your information and submit your application quickly.

You can apply for the Akums Drugs and Pharmaceuticals IPO at Alice Blue in just a few clicks!

Loading
Read More News
स्टॉक चर्चा में आया म्यूचुअल फंड्स ने ब्लॉक डील के जरिए हिस्सेदारी खरीदी

स्टॉक चर्चा में आया: SBI, AXIS और ICICI म्यूचुअल फंड के कंपनी में ब्लॉक डील के जरिए हिस्सेदारी खरीदने से।

बड़ी म्यूचुअल फंड्स द्वारा महत्वपूर्ण ब्लॉक डील और हिस्सेदारी खरीदी से कंपनी के भविष्य प्रदर्शन पर सकारात्मक दृष्टिकोण और बढ़ती